Mariike Kuijjer
@mkuijjer.bsky.social
480 followers 210 following 580 posts
Associate Professor in Cancer Data Science at iCAN, University of Helsinki, Group leader in Computational Biology and Systems Medicine at NCMBM, University of Oslo. Research focus on precision network medicine in cancer.
Posts Media Videos Starter Packs
Pinned
mkuijjer.bsky.social
Back from a wonderful joint group retreat in Fornebu 🌊🇳🇴 We had lots of pork neck, 🌶️ gossip, and fruitful discussions. Hope to do this again soon to keep connections strong 💪 So lucky to be part of this brilliant team of scientists 💫 Read more here: www.kuijjerlab.org/blog/group-r...
mkuijjer.bsky.social
This work presents a major milestone by the group, led by Tatiana Belova, with contributions from current and former group members. Funding sources incl the Norwegian Research Council, Norwegian Cancer Society, iCAN, and NCMBM 🙏 Code is available in Snakemake 🐍 pipeline: github.com/kuijjerlab/P...
mkuijjer.bsky.social
Finally, we mapped TFs modulating PD-L1, with their regulatory profiles linked to survival. Recurrent TFs included both known modulators (incl with/without known binding sites) and TFs with yet unknown role in PD-L1 regulation, highlighting candidate targets for modulating immune checkpoint activity
mkuijjer.bsky.social
Strikingly, PD1 signaling heterogeneity associated with survival in about half of these (12/23) cancer types, but only associated with immune infiltrate in a subset (5/12, 👇), suggesting that, in many cancers, dysregulation may arise from tumor-intrinsic regulatory programs
mkuijjer.bsky.social
This motivated us to map the regulatory heterogeneity per cancer type with our tool PORCUPINE, analyzing the complete networks. This identified several recurrently heterogeneously regulated pathways (categories and pathways from top category 👇), with PD1 signaling dysregulated in 23/33 cancer types!
mkuijjer.bsky.social
We reconstructed sample-specific networks with our NetZoo tools PANDA and LIONESS: nearly 10k networks for 33 cancer types. Visualizing and clustering these networks on Gene Targeting Scores indicated that, for most cancer types, networks stratify patients distinctly from expression data (e.g. 👇)
mkuijjer.bsky.social
Until now, patient-specific regulatory networks have mostly been studied in individual cancer types. In our latest BioRxiv pre-print, we took this to the next level, performing a large-scale, pan-cancer network analysis of patient-specific regulatory landscapes: www.biorxiv.org/content/10.1...
mkuijjer.bsky.social
October welcomes 2 new group members in the Kuijjer group! Welcome Samantha Martin and Turan Koç! More info: www.kuijjerlab.org/blog/new-gro...
New group members
Kuijjer Lab website
www.kuijjerlab.org
mkuijjer.bsky.social
Poster discussion ongoing, with our iCANDOC PhD student Panos presenting benchmarking of single sample network subtyping 📜
mkuijjer.bsky.social
Nice location for the iCAN 2025 symposium!
mkuijjer.bsky.social
Great spot for a pause and outdoor dinner in between work and dance, in beautiful Copenhagen 🧜‍♀️🇩🇰
mkuijjer.bsky.social
Touring the Nordics and Europe for science in early fall brings sundogs, rainbows, and beautiful clouds 🇸🇪🇫🇮🇩🇪🇳🇴🇩🇰 Also good to have packed rain gear 🚲🌦
mkuijjer.bsky.social
September starts strong! Welcome Ceren Pajanoja to our Helsinki group as postdoc, and congrats to Romana Pop for continuing as a joint NCMBM/OUS postdoc with our Oslo group & Anita Sveen. Excited to see the science they’ll drive in the years ahead! Info 👇
www.kuijjerlab.org/blog/new-gro...
New group members
Kuijjer Lab website
www.kuijjerlab.org
mkuijjer.bsky.social
Back from a wonderful joint group retreat in Fornebu 🌊🇳🇴 We had lots of pork neck, 🌶️ gossip, and fruitful discussions. Hope to do this again soon to keep connections strong 💪 So lucky to be part of this brilliant team of scientists 💫 Read more here: www.kuijjerlab.org/blog/group-r...
mkuijjer.bsky.social
At the Meilahti campus bus stop, on my way to the group retreat in Fornebu 😍
mkuijjer.bsky.social
I’m surprised to see that some funders still ask for impact factors in grant applications, even though institutions like @helsinki.fi have signed DORA. It puts applicants in an awkward spot
mkuijjer.bsky.social
Happy to have started as director of the iCANDOC doctoral education pilot in precision cancer medicine! Looking forward to supporting the development of doctoral training in 🇫🇮🧑‍🎓 More info: ican.fi/icandoc/
iCANDOC doctoral education pilot - iCAN
The iCANDOC Precision Cancer Medicine (PCM) pilot is the largest Ministry of Education and Culture’s doctoral education pilots, awarded a total of
ican.fi
mkuijjer.bsky.social
Sundog above Helsinki 🌈🌥🇫🇮
mkuijjer.bsky.social
Beautiful halo on my ride home 🇫🇮🌥
Reposted by Mariike Kuijjer
ncmbm.bsky.social
📣 We’re recruiting 1-2 Group Leaders! NCMBM is looking for early-career researchers ready to establish their independent research groups!

🧬 With an attractive start-up package, help us shape the future of molecular biosciences and medicine in 🇳🇴 and be part of the @nordicembl.bsky.social!
mkuijjer.bsky.social
Join us tomorrow at noon to learn more on spatial tumor ecosystems from @afarkkila.bsky.social from @farkkilab.bsky.social ! The talk will be at Forum, @forskningsparken.bsky.social